Coates, L., Garrood, T., Gullick, N., Helliwell, P., Kent, T., Marks, J., . . . McInnes, I. (2022). Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Oxford University Press.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিCoates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিCoates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.